• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For August 7, 2023

    8/7/23 12:12:28 PM ET
    $ACM
    $ACVA
    $ADEA
    $AEL
    Military/Government/Technical
    Consumer Discretionary
    Real Estate
    Real Estate
    Get the next $ACM alert in real time by email

    Companies Reporting Before The Bell

    • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss at $0.44 per share on revenue of $153.69 million.

    • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.09 per share on revenue of $289.53 million.

    • Hawaiian Electric Indus (NYSE:HE) is estimated to report quarterly earnings at $0.52 per share on revenue of $845.37 million.

    • Gogo (NASDAQ:GOGO) is projected to report quarterly earnings at $0.13 per share on revenue of $103.25 million.

    • BioNTech (NASDAQ:BNTX) is estimated to report quarterly loss at $0.75 per share on revenue of $944.34 million.

    • AG Mortgage IT (NYSE:MITT) is expected to report quarterly earnings at $0.11 per share on revenue of $14.15 million.

    • Viatris (NASDAQ:VTRS) is estimated to report quarterly earnings at $0.71 per share on revenue of $3.89 billion.

    • Tyson Foods (NYSE:TSN) is expected to report quarterly earnings at $0.34 per share on revenue of $13.78 billion.

    • Treehouse Foods (NYSE:THS) is expected to report quarterly earnings at $0.40 per share on revenue of $829.85 million.

    • KKR & Co (NYSE:KKR) is estimated to report quarterly earnings at $0.71 per share on revenue of $924.31 million.

    • Henry Schein (NASDAQ:HSIC) is expected to report quarterly earnings at $1.25 per share on revenue of $3.11 billion.

    • Graham (NYSE:GHM) is expected to report quarterly loss at $0.04 per share on revenue of $39.68 million.

    • Freshpet (NASDAQ:FRPT) is expected to report quarterly loss at $0.38 per share on revenue of $185.75 million.

    • Elanco Animal Health (NYSE:ELAN) is projected to report quarterly earnings at $0.05 per share on revenue of $1.04 billion.

    • Danaos (NYSE:DAC) is estimated to report quarterly earnings at $6.67 per share on revenue of $225.75 million.

    • Forza X1 (NASDAQ:FRZA) is estimated to report earnings for its second quarter.

    • Protalix BioTherapeutics (AMEX:PLX) is projected to report quarterly loss at $0.04 per share on revenue of $10.22 million.

    • Exagen (NASDAQ:XGN) is projected to report quarterly loss at $0.48 per share on revenue of $10.97 million.

    • Arcus Biosciences (NYSE:RCUS) is estimated to report quarterly loss at $1.00 per share on revenue of $35.86 million.

    • Lincoln Educational Servs (NASDAQ:LINC) is estimated to report quarterly loss at $0.02 per share on revenue of $84.37 million.

    • Genius Sports (NYSE:GENI) is projected to report quarterly loss at $0.04 per share on revenue of $80.15 million.

    • Delek Logistics Partners (NYSE:DKL) is estimated to report quarterly earnings at $0.81 per share on revenue of $281.25 million.

    • Delek US Hldgs (NYSE:DK) is estimated to report quarterly earnings at $0.70 per share on revenue of $3.60 billion.

    • Compugen (NASDAQ:CGEN) is estimated to report earnings for its second quarter.

    • Axsome Therapeutics (NASDAQ:AXSM) is estimated to report quarterly loss at $1.24 per share on revenue of $40.19 million.

    • Federal Agricultural (NYSE:AGM) is estimated to report quarterly earnings at $3.10 per share on revenue of $77.32 million.

    • Overseas Shipholding Gr (NYSE:OSG) is likely to report earnings for its second quarter.

    • Genie Energy (NYSE:GNE) is projected to report earnings for its second quarter.

    • Phinia (NYSE:PHIN) is estimated to report earnings for its second quarter.

    • Quantum-Si (NASDAQ:QSI) is likely to report quarterly loss at $0.20 per share on revenue of $400 thousand.

    • CSI Compressco (NASDAQ:CCLP) is projected to report earnings for its second quarter.

    Companies Reporting After The Bell

    • United Fire Gr (NASDAQ:UFCS) is expected to report quarterly earnings at $0.19 per share on revenue of $266.80 million.

    • Tidewater (NYSE:TDW) is projected to report quarterly earnings at $0.74 per share on revenue of $220.45 million.

    • EchoStar (NASDAQ:SATS) is estimated to report quarterly earnings at $0.23 per share on revenue of $451.90 million.

    • Redwire (NYSE:RDW) is likely to report quarterly loss at $0.16 per share on revenue of $58.23 million.

    • Ready Capital (NYSE:RC) is estimated to report quarterly earnings at $0.36 per share on revenue of $62.72 million.

    • ePlus (NASDAQ:PLUS) is likely to report quarterly earnings at $0.99 per share on revenue of $487.55 million.

    • Palantir Technologies (NYSE:PLTR) is projected to report quarterly earnings at $0.05 per share on revenue of $533.88 million.

    • Paramount Global (NASDAQ:PARAA) is projected to report quarterly loss at $0.01 per share on revenue of $7.43 billion.

    • Paramount Global (NASDAQ:PARA) is projected to report quarterly loss at $0.01 per share on revenue of $7.43 billion.

    • MannKind (NASDAQ:MNKD) is estimated to report quarterly loss at $0.04 per share on revenue of $42.03 million.

    • Mineralys Therapeutics (NASDAQ:MLYS) is likely to report earnings for its second quarter.

    • Medifast (NYSE:MED) is projected to report quarterly earnings at $1.44 per share on revenue of $253.47 million.

    • Kinetik Holdings (NYSE:KNTK) is estimated to report quarterly earnings at $0.32 per share on revenue of $296.33 million.

    • Hims & Hers Health (NYSE:HIMS) is expected to report quarterly loss at $0.06 per share on revenue of $204.62 million.

    • Enanta Pharma (NASDAQ:ENTA) is estimated to report quarterly loss at $2.38 per share on revenue of $15.88 million.

    • Douglas Elliman (NYSE:DOUG) is projected to report quarterly loss at $0.12 per share on revenue of $242.06 million.

    • Diamond Offshore Drilling (NYSE:DO) is projected to report quarterly loss at $0.11 per share on revenue of $289.00 million.

    • Capricor Therapeutics (NASDAQ:CAPR) is likely to report quarterly loss at $0.35 per share on revenue of $1.50 million.

    • BellRing Brands (NYSE:BRBR) is projected to report quarterly earnings at $0.32 per share on revenue of $441.43 million.

    • Asure Software (NASDAQ:ASUR) is estimated to report quarterly earnings at $0.01 per share on revenue of $25.36 million.

    • Alto Ingredients (NASDAQ:ALTO) is projected to report quarterly loss at $0.07 per share on revenue of $306.53 million.

    • Reshape Lifesciences (NASDAQ:RSLS) is likely to report quarterly loss at $1.79 per share on revenue of $2.61 million.

    • P3 Health Partners (NASDAQ:PIII) is likely to report quarterly loss at $0.24 per share on revenue of $303.30 million.

    • ONEOK (NYSE:OKE) is expected to report quarterly earnings at $1.00 per share on revenue of $4.85 billion.

    • Kemper (NYSE:KMPR) is expected to report quarterly loss at $0.38 per share on revenue of $1.33 billion.

    • Intl Flavors & Fragrances (NYSE:IFF) is expected to report quarterly earnings at $1.10 per share on revenue of $3.11 billion.

    • HighPeak Energy (NASDAQ:HPK) is estimated to report quarterly earnings at $0.45 per share on revenue of $245.84 million.

    • FS KKR Capital (NYSE:FSK) is estimated to report quarterly earnings at $0.76 per share on revenue of $449.67 million.

    • Augmedix (NASDAQ:AUGX) is estimated to report quarterly loss at $0.13 per share on revenue of $10.41 million.

    • Apollo Medical Hlgs (NASDAQ:AMEH) is likely to report quarterly earnings at $0.28 per share on revenue of $341.10 million.

    • Hallador Energy (NASDAQ:HNRG) is projected to report quarterly earnings at $0.31 per share on revenue of $158.00 million.

    • INmune Bio (NASDAQ:INMB) is likely to report earnings for its second quarter.

    • Zai Lab (NASDAQ:ZLAB) is expected to report quarterly loss at $0.74 per share on revenue of $71.40 million.

    • Cactus (NYSE:WHD) is likely to report quarterly earnings at $0.69 per share on revenue of $302.53 million.

    • Veeco Instruments (NASDAQ:VECO) is projected to report quarterly earnings at $0.30 per share on revenue of $157.50 million.

    • Tabula Rasa HealthCare (NASDAQ:TRHC) is estimated to report quarterly loss at $0.14 per share on revenue of $88.82 million.

    • Tactile Systems Tech (NASDAQ:TCMD) is projected to report quarterly loss at $0.07 per share on revenue of $65.48 million.

    • Theravance Biopharma (NASDAQ:TBPH) is estimated to report quarterly loss at $0.16 per share on revenue of $15.24 million.

    • Service Properties Trust (NASDAQ:SVC) is likely to report earnings for its second quarter.

    • Sterling Infrastructure (NASDAQ:STRL) is projected to report quarterly earnings at $0.93 per share on revenue of $491.50 million.

    • SkyWater Technology (NASDAQ:SKYT) is projected to report quarterly loss at $0.09 per share on revenue of $64.30 million.

    • SI-BONE (NASDAQ:SIBN) is estimated to report quarterly loss at $0.41 per share on revenue of $32.24 million.

    • Superior Gr of Cos (NASDAQ:SGC) is expected to report quarterly earnings at $0.09 per share on revenue of $134.46 million.

    • Sabra Health Care REIT (NASDAQ:SBRA) is estimated to report earnings for its second quarter.

    • RxSight (NASDAQ:RXST) is expected to report quarterly loss at $0.47 per share on revenue of $19.21 million.

    • Ranger Energy Services (NYSE:RNGR) is projected to report quarterly earnings at $0.42 per share on revenue of $171.00 million.

    • Riley Exploration Permian (AMEX:REPX) is likely to report quarterly earnings at $1.98 per share on revenue of $96.73 million.

    • FreightCar America (NASDAQ:RAIL) is expected to report quarterly loss at $0.12 per share on revenue of $95.40 million.

    • PowerSchool Holdings (NYSE:PWSC) is likely to report quarterly earnings at $0.23 per share on revenue of $171.28 million.

    • Primoris Services (NYSE:PRIM) is expected to report quarterly earnings at $0.50 per share on revenue of $1.35 billion.

    • PRA Group (NASDAQ:PRAA) is expected to report quarterly loss at $0.16 per share on revenue of $204.21 million.

    • Paymentus Holdings (NYSE:PAY) is estimated to report quarterly earnings at $0.01 per share on revenue of $144.36 million.

    • Par Pacific Hldgs (NYSE:PARR) is projected to report quarterly earnings at $1.20 per share on revenue of $1.57 billion.

    • Ocular Therapeutix (NASDAQ:OCUL) is expected to report quarterly loss at $0.29 per share on revenue of $14.64 million.

    • Nelnet (NYSE:NNI) is projected to report quarterly earnings at $1.08 per share on revenue of $314.81 million.

    • MagnaChip Semiconductor (NYSE:MX) is projected to report quarterly loss at $0.23 per share on revenue of $60.50 million.

    • Microvast Holdings (NASDAQ:MVST) is likely to report quarterly loss at $0.09 per share on revenue of $64.19 million.

    • Manitowoc Co (NYSE:MTW) is projected to report quarterly earnings at $0.25 per share on revenue of $511.22 million.

    • MRC Global (NYSE:MRC) is expected to report quarterly earnings at $0.36 per share on revenue of $910.15 million.

    • Gladstone Land (NASDAQ:LAND) is projected to report earnings for its second quarter.

    • James River Gr Hldgs (NASDAQ:JRVR) is projected to report quarterly earnings at $0.49 per share on revenue of $214.70 million.

    • JELD-WEN Holding (NYSE:JELD) is projected to report quarterly earnings at $0.33 per share on revenue of $1.10 billion.

    • Inogen (NASDAQ:INGN) is estimated to report quarterly loss at $0.64 per share on revenue of $93.27 million.

    • Helios Technologies (NYSE:HLIO) is likely to report quarterly earnings at $0.82 per share on revenue of $219.45 million.

    • Golub Capital BDC (NASDAQ:GBDC) is estimated to report quarterly earnings at $0.43 per share on revenue of $151.24 million.

    • FibroGen (NASDAQ:FGEN) is estimated to report quarterly loss at $0.72 per share on revenue of $34.17 million.

    • EverQuote (NASDAQ:EVER) is expected to report quarterly loss at $0.33 per share on revenue of $71.56 million.

    • EverCommerce (NASDAQ:EVCM) is expected to report quarterly loss at $0.08 per share on revenue of $170.16 million.

    • Ellington Financial (NYSE:EFC) is likely to report quarterly earnings at $0.44 per share on revenue of $26.55 million.

    • Viant Technology (NASDAQ:DSP) is expected to report quarterly earnings at $0.01 per share on revenue of $33.10 million.

    • DocGo (NASDAQ:DCGO) is expected to report quarterly earnings at $0.03 per share on revenue of $119.63 million.

    • CoreCivic (NYSE:CXW) is estimated to report earnings for its second quarter.

    • Capital Southwest (NASDAQ:CSWC) is likely to report quarterly earnings at $0.63 per share on revenue of $38.90 million.

    • Cepton (NASDAQ:CPTN) is likely to report quarterly loss at $0.07 per share on revenue of $3.30 million.

    • Compass (NYSE:COMP) is estimated to report quarterly loss at $0.05 per share on revenue of $1.53 billion.

    • Clarus (NASDAQ:CLAR) is estimated to report quarterly earnings at $0.14 per share on revenue of $91.92 million.

    • Chegg (NYSE:CHGG) is likely to report quarterly earnings at $0.28 per share on revenue of $176.19 million.

    • Cabot (NYSE:CBT) is likely to report quarterly earnings at $1.56 per share on revenue of $1.15 billion.

    • Cara Therapeutics (NASDAQ:CARA) is likely to report quarterly loss at $0.56 per share on revenue of $6.49 million.

    • CrossAmerica Partners (NYSE:CAPL) is estimated to report quarterly earnings at $0.15 per share on revenue of $1.20 billion.

    • Beyond Meat (NASDAQ:BYND) is expected to report quarterly loss at $0.81 per share on revenue of $111.28 million.

    • Bowman Consulting Group (NASDAQ:BWMN) is expected to report quarterly earnings at $0.15 per share on revenue of $81.41 million.

    • BRT Apartments (NYSE:BRT) is projected to report earnings for its second quarter.

    • Bridge Investment Group (NYSE:BRDG) is estimated to report quarterly earnings at $0.20 per share on revenue of $78.78 million.

    • Brookdale Senior Living (NYSE:BKD) is projected to report quarterly loss at $0.24 per share on revenue of $747.04 million.

    • Biodesix (NASDAQ:BDSX) is estimated to report quarterly loss at $0.21 per share on revenue of $11.38 million.

    • Axogen (NASDAQ:AXGN) is projected to report quarterly loss at $0.15 per share on revenue of $39.40 million.

    • American States Water (NYSE:AWR) is projected to report quarterly earnings at $0.79 per share on revenue of $128.00 million.

    • ATI Physical Therapy (NYSE:ATIP) is estimated to report quarterly loss at $3.50 per share on revenue of $170.17 million.

    • Arrowhead Pharma (NASDAQ:ARWR) is projected to report quarterly loss at $0.58 per share on revenue of $48.19 million.

    • ARKO (NASDAQ:ARKO) is estimated to report quarterly earnings at $0.21 per share on revenue of $2.46 billion.

    • Argo Gr Intl Hldgs (NYSE:ARGO) is estimated to report quarterly earnings at $0.40 per share on revenue of $348.80 million.

    • Arcturus Therapeutics (NASDAQ:ARCT) is expected to report quarterly earnings at $0.09 per share on revenue of $71.05 million.

    • Aquestive Therapeutics (NASDAQ:AQST) is likely to report quarterly loss at $0.11 per share on revenue of $10.76 million.

    • Ambac Financial Group (NYSE:AMBC) is expected to report quarterly loss at $0.06 per share on revenue of $48.80 million.

    • Akoya Biosciences (NASDAQ:AKYA) is expected to report quarterly loss at $0.44 per share on revenue of $22.17 million.

    • Acutus Medical (NASDAQ:AFIB) is expected to report quarterly loss at $0.61 per share on revenue of $4.60 million.

    • American Equity Inv (NYSE:AEL) is likely to report quarterly earnings at $1.65 per share on revenue of $555.03 million.

    • Adeia (NASDAQ:ADEA) is estimated to report quarterly earnings at $0.22 per share on revenue of $84.17 million.

    • ACV Auctions (NASDAQ:ACVA) is likely to report quarterly loss at $0.07 per share on revenue of $119.44 million.

    • Turtle Beach (NASDAQ:HEAR) is likely to report quarterly loss at $0.33 per share on revenue of $51.33 million.

    • Maravai LifeSciences (NASDAQ:MRVI) is estimated to report quarterly earnings at $0.01 per share on revenue of $70.30 million.

    • Kyndryl Hldgs (NYSE:KD) is estimated to report quarterly loss at $0.55 per share on revenue of $4.24 billion.

    • National Storage (NYSE:NSA) is expected to report earnings for its second quarter.

    • Crane NXT (NYSE:CXT) is expected to report quarterly earnings at $0.92 per share on revenue of $337.80 million.

    • ICU Medical (NASDAQ:ICUI) is estimated to report quarterly earnings at $1.55 per share on revenue of $562.90 million.

    • Primerica (NYSE:PRI) is projected to report quarterly earnings at $3.79 per share on revenue of $707.34 million.

    • ShockWave Medical (NASDAQ:SWAV) is estimated to report quarterly earnings at $0.87 per share on revenue of $173.30 million.

    • Essential Utilities (NYSE:WTRG) is likely to report quarterly earnings at $0.34 per share on revenue of $467.99 million.

    • Lucid Gr (NASDAQ:LCID) is estimated to report quarterly loss at $0.35 per share on revenue of $201.94 million.

    • Coterra Energy (NYSE:CTRA) is expected to report quarterly earnings at $0.36 per share on revenue of $1.28 billion.

    • Teradata (NYSE:TDC) is estimated to report quarterly earnings at $0.45 per share on revenue of $443.77 million.

    • Spirit Realty Cap (NYSE:SRC) is likely to report earnings for its second quarter.

    • AECOM (NYSE:ACM) is estimated to report quarterly earnings at $0.95 per share on revenue of $3.49 billion.

    • Five9 (NASDAQ:FIVN) is estimated to report quarterly earnings at $0.39 per share on revenue of $214.11 million.

    • RingCentral (NYSE:RNG) is expected to report quarterly earnings at $0.75 per share on revenue of $536.04 million.

    • Celanese (NYSE:CE) is projected to report quarterly earnings at $2.46 per share on revenue of $2.84 billion.

    • Alteryx (NYSE:AYX) is likely to report quarterly loss at $0.66 per share on revenue of $182.15 million.

    • Skyworks Solutions (NASDAQ:SWKS) is likely to report quarterly earnings at $1.67 per share on revenue of $1.07 billion.

    • T2 Biosystems (NASDAQ:TTOO) is likely to report quarterly loss at $0.27 per share on revenue of $2.03 million.

    • Apartment Inv & Mgmt (NYSE:AIV) is expected to report earnings for its second quarter.

    • Red Violet (NASDAQ:RDVT) is estimated to report earnings for its second quarter.

    • Journey Medical (NASDAQ:DERM) is estimated to report quarterly loss at $0.33 per share on revenue of $14.81 million.

    • AEye (NASDAQ:LIDR) is projected to report quarterly loss at $0.09 per share on revenue of $600 thousand.

    • James Hardie Industries (NYSE:JHX) is projected to report earnings for its first quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACM
    $ACVA
    $ADEA
    $AEL

    CompanyDatePrice TargetRatingAnalyst
    Palantir Technologies Inc.
    $PLTR
    2/27/2026$150.00Buy
    Rosenblatt
    MannKind Corporation
    $MNKD
    2/27/2026$3.50Outperform → Sector Perform
    RBC Capital Mkts
    Palantir Technologies Inc.
    $PLTR
    2/27/2026$150.00Neutral → Buy
    UBS
    Biodesix Inc.
    $BDSX
    2/27/2026Mkt Perform → Outperform
    William Blair
    Par Pacific Holdings Inc.
    $PARR
    2/27/2026$39.00 → $48.00Buy
    TD Cowen
    ONEOK Inc.
    $OKE
    2/25/2026Outperform → Peer Perform
    Wolfe Research
    ACV Auctions Inc.
    $ACVA
    2/24/2026Mkt Perform → Outperform
    Barrington Research
    ACV Auctions Inc.
    $ACVA
    2/24/2026$7.00Buy → Neutral
    Citigroup
    More analyst ratings

    $ACM
    $ACVA
    $ADEA
    $AEL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER issued to ICU MEDICAL INC

    Submission status for ICU MEDICAL INC's drug POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (SUPPL-8) with active ingredient POTASSIUM CHLORIDE; SODIUM CHLORIDE has changed to 'Approval' on 05/15/2023. Application Category: ANDA, Application Number: 078446, Application Classification: Labeling

    5/17/23 4:40:03 AM ET
    $ICUI
    Medical/Dental Instruments
    Health Care

    FDA Approval for AUVELITY issued to AXSOME THERAPEUTICS, INC.

    Submission status for AXSOME THERAPEUTICS, INC.'s drug AUVELITY (ORIG-1) with active ingredient DEXTROMETHORPHAN HYDROBROMIDE AND BUPROPION HYDROCHLORIDE has changed to 'Approval' on 08/18/2022. Application Category: NDA, Application Number: 215430, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    8/19/22 12:36:14 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACM
    $ACVA
    $ADEA
    $AEL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director George Walter N. bought $49,795 worth of shares (630 units at $79.04), increasing direct ownership by 1% to 47,157 units (SEC Form 4)

    4 - Freshpet, Inc. (0001611647) (Issuer)

    2/26/26 4:07:13 PM ET
    $FRPT
    Packaged Foods
    Consumer Staples

    Director Lindstrom Richard L Md bought $461,354 worth of shares (60,229 units at $7.66), increasing direct ownership by 32% to 246,933 units (SEC Form 4)

    4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)

    2/24/26 6:13:03 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Cohler Matt bought $4,514,429 worth of shares (43,872 units at $102.90), increasing direct ownership by 2,733% to 45,477 units (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    2/18/26 6:38:22 PM ET
    $KKR
    Investment Managers
    Finance

    $ACM
    $ACVA
    $ADEA
    $AEL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rosenblatt initiated coverage on Palantir Technologies with a new price target

    Rosenblatt initiated coverage of Palantir Technologies with a rating of Buy and set a new price target of $150.00

    2/27/26 8:31:30 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Mannkind downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Mannkind from Outperform to Sector Perform and set a new price target of $3.50

    2/27/26 8:29:08 AM ET
    $MNKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Palantir Technologies upgraded by UBS with a new price target

    UBS upgraded Palantir Technologies from Neutral to Buy and set a new price target of $150.00

    2/27/26 8:22:27 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $ACM
    $ACVA
    $ADEA
    $AEL
    Leadership Updates

    Live Leadership Updates

    View All

    Ready Capital Corporation Announces Leadership Changes

    NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ready Capital Corporation (NYSE:RC) (the "Company") today announced the appointment of Dominick Scali as Chief Credit Officer of the Company and Co-President of ReadyCap Commercial, LLC, the Company's commercial real estate lending business. Mr. Scali has been a Managing Director and Co-Head of Bridge Lending with the Company since 2015. Prior to that, he was head of credit and underwriting for Doral Bank's national bridge lending platform and held positions in credit and originations at Anglo Irish bank. He began his career at Citigroup working within Citibank's affordable housing department. Mr. Scali holds a B.A. from Columbia University. Ad

    2/26/26 4:25:00 PM ET
    $RC
    Real Estate Investment Trusts
    Real Estate

    Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

    Eucalyptus is a consumer healthcare leader in Australia, the UK and Germany, with expanding new operations in Japan and Canada. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital health, accelerating the company's ability to bring access to high-quality, personalized care to more people across the world. As its US business continues to grow, Hims & Hers will be well-positioned, upon closing of the acquisition, to expand into Australia and Japan and deepen its presence in the UK, Germany, and Canada. The terms of the transaction have been structu

    2/19/26 6:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

    Board-certified allergist and leading food allergy and anaphylaxis researcher joins Aquestive to support Anaphylm™ (dibutepinephrine) sublingual film NDA resubmission and pipeline WARREN, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Matthew Greenhawt, MD, MBA, MSc, as Chief Medical Officer, strengthening its leadership team as the Company prepares to resubmit its Anaphylm™ New Drug Application (NDA) to the United Stated Food and Drug Admi

    2/18/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACM
    $ACVA
    $ADEA
    $AEL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arcus Biosciences Inc.

    SC 13D/A - Arcus Biosciences, Inc. (0001724521) (Subject)

    12/17/24 9:52:58 PM ET
    $RCUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/17/24 5:51:04 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ACM
    $ACVA
    $ADEA
    $AEL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RingCentral to Present at Morgan Stanley Investor Conference

    RingCentral, Inc. (NYSE:RNG), a global leader in AI-powered business communications, today announced that members of its management team are scheduled to present at the following investor conference: Morgan Stanley Technology, Media & Telecom Conference Date: Tuesday, March 3, 2026 Time: 10:45 a.m. PT / 1:45 p.m. ET A live webcast and replay of the fireside presentation will be accessible on the Company's investor relations website at ir.ringcentral.com. About RingCentral RingCentral is a global leader in agentic voice AI–powered cloud business communications, delivering an integrated platform for business phone, SMS, contact center, workforce engagement management, video collaborat

    2/27/26 4:05:00 PM ET
    $RNG
    EDP Services
    Technology

    Mach 2 and Beyond: Aerospace Enters Its Biggest Spending Cycle

    Issued on behalf of Starfighters SpaceVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity Insider News Commentary -- Congress approved $839 billion in Pentagon funding for fiscal 2026, $8 billion more than the Department of Defense requested, with billions earmarked for space, missile defense, and advanced aerospace systems[1]. The Pentagon's $152 billion reconciliation spending plan allocates $2.2 billion specifically to accelerate hypersonic defense systems and $5.6 billion for space-based interceptors[2]. Companies positioned across aerospace testing, defense technology, and space infrastructure include Starfighters Space (NYSE-A: FJET), Kratos Defense (NASDAQ:KTOS), V2X (NYSE:VVX), Redwire (NYS

    2/27/26 11:24:00 AM ET
    $FJET
    $KTOS
    $LUNR
    Air Freight/Delivery Services
    Consumer Discretionary
    Military/Government/Technical
    Industrials

    Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength

    DENVER, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Markets reward momentum and trends may sustain when execution follows headlines. Several companies are now moving beyond announcements and into operational validation, positioning themselves for potential continued follow-through. From biomaterials scale-up to enterprise AI deployment and disciplined capital allocation, these names are building narratives that extend beyond a single news cycle. Kraig Biocraft Laboratories: From Strategy to Scale Activity has accelerated at Kraig Biocraft Laboratories (OTCQB:KBLB) following confirmation that its 2026 production plan has officially transitioned from roadmap to execution. The company has moved bio

    2/27/26 9:45:46 AM ET
    $ENSC
    $PLTR
    $RXT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    $ACM
    $ACVA
    $ADEA
    $AEL
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at INmune Bio Inc. on Jun 26

    Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

    6/26/24 2:54:12 PM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACM
    $ACVA
    $ADEA
    $AEL
    Financials

    Live finance-specific insights

    View All

    Gogo Announces Fourth Quarter and Full Year 2025 Results

    Total Q4 Revenue of $230.6 million, up 67% Year-over-Year; Service Revenue of $191.9 million, up 61% Year-over-Year  Full Year Results at High End of 2025 Guidance Range for Revenue, Adjusted EBITDA and Free Cash Flow Gogo Galileo and 5G Expected to Ramp in 2026 Company Provides 2026 Financial Guidance BROOMFIELD, Colo., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Gogo Inc. (NASDAQ:GOGO) ("Gogo" or the "Company"), a leading global provider of broadband connectivity services for the business and military/government aviation markets, today announced its financial results for the quarter ended December 31, 2025 and full year results for 2025. Fourth quarter and full year 2025 financial results fo

    2/27/26 7:00:00 AM ET
    $GOGO
    Telecommunications Equipment
    Consumer Discretionary

    AECOM to provide design, environmental, and project management services for Sound Transit's Seattle-area regional transit expansion

    AECOM (NYSE:ACM), the trusted global infrastructure leader, today announced it has been selected by Sound Transit to deliver design, planning and environmental services, along with project and construction management (PMCM) services through three multiple-award task order contracts (MATOCs). These contracts will provide a basis for the next wave of planning, design, and delivery for the Seattle region's light rail, commuter rail, and bus network. As the prime firm on the five-year Design MATOC, AECOM will lead the delivery of civil and structural engineering work, with a project scope ranging from preliminary engineering to full design development. In aggregate, Sound Transit has issued a

    2/27/26 6:55:00 AM ET
    $ACM
    Military/Government/Technical
    Consumer Discretionary

    Delek US Holdings Reports Fourth Quarter 2025 Results

     Delek US reported fourth quarter net income of $78.3 million or $1.26 per share, adjusted net income of $143.0 million or $2.31 per share and adjusted EBITDA of $374.8 million Excluding the impacts of SREs, adjusted EPS was $0.44 per share and adjusted EBITDA was $225.5 million Further advanced key objectives of Enterprise Optimization Plan ("EOP") Increased the annual run-rate cash flow improvements to ~$200 million Recognized ~$50 million of improvements in 4Q'25 Announced restructuring of its Inventory Intermediation Agreement which will result in incremental free cash flow generation of at least $40 million Delek Logistics reported record financial performance and

    2/27/26 6:30:00 AM ET
    $DK
    $DKL
    Integrated oil Companies
    Energy
    Natural Gas Distribution

    $ACM
    $ACVA
    $ADEA
    $AEL
    SEC Filings

    View All

    SEC Form 10-K filed by Hawaiian Electric Industries Inc.

    10-K - HAWAIIAN ELECTRIC INDUSTRIES INC (0000354707) (Filer)

    2/27/26 4:09:21 PM ET
    $HE
    Electric Utilities: Central
    Utilities

    Hawaiian Electric Industries Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HAWAIIAN ELECTRIC INDUSTRIES INC (0000354707) (Filer)

    2/27/26 4:05:57 PM ET
    $HE
    Electric Utilities: Central
    Utilities

    Ocular Therapeutix Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - OCULAR THERAPEUTIX, INC (0001393434) (Filer)

    2/27/26 4:02:39 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACM
    $ACVA
    $ADEA
    $AEL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Cutillo Joseph A was granted 30,488 shares and covered exercise/tax liability with 11,668 shares, increasing direct ownership by 4% to 490,593 units (SEC Form 4)

    4 - STERLING INFRASTRUCTURE, INC. (0000874238) (Issuer)

    2/27/26 4:05:37 PM ET
    $STRL
    Military/Government/Technical
    Industrials

    General Counsel, Corporate Sec Wolf Mark D. was granted 2,996 shares and covered exercise/tax liability with 1,193 shares, increasing direct ownership by 6% to 30,637 units (SEC Form 4)

    4 - STERLING INFRASTRUCTURE, INC. (0000874238) (Issuer)

    2/27/26 4:05:21 PM ET
    $STRL
    Military/Government/Technical
    Industrials

    SVP OF OPERATIONS Rowley Paul J was granted 37 shares and covered exercise/tax liability with 86 shares, decreasing direct ownership by 0.76% to 6,450 units (SEC Form 4)

    4 - AMERICAN STATES WATER CO (0001056903) (Issuer)

    2/27/26 2:39:52 PM ET
    $AWR
    Water Supply
    Utilities